Mark T. Muller
Affiliations: | Ohio State University, Columbus, Columbus, OH |
Area:
Molecular Biology, OncologyGoogle:
"Mark Muller"Children
Sign in to add traineeDan Luo | grad student | 1997 | Ohio State (BME Tree) |
Rong Ju | grad student | 2002 | Ohio State |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang Y, Rakela S, Chambers JW, et al. (2019) Kinetic Study of DNA Topoisomerases by Supercoiling-Dependent Fluorescence Quenching. Acs Omega. 4: 18413-18422 |
Allen B, Pezone A, Porcellini A, et al. (2017) Non-Homologous end joining induced alterations in DNA methylation: A source of permanent epigenetic change. Oncotarget |
Pezone A, Russo G, Tramontano A, et al. (2017) High-coverage methylation data of a gene model before and after DNA damage and homologous repair. Scientific Data. 4: 170043 |
Cuozzo C, Porcellini A, Angrisano T, et al. (2017) Correction: DNA Damage, Homology-Directed Repair, and DNA Methylation. Plos Genetics. 13: e1006605 |
Russo G, Landi R, Pezone A, et al. (2016) DNA damage and Repair Modify DNA methylation and Chromatin Domain of the Targeted Locus: Mechanism of allele methylation polymorphism. Scientific Reports. 6: 33222 |
Allen BN, Masternak M, Muller M. (2016) Abstract A43: DNA repair by non-homologous end joining induced gene silencing via DNA hypermethylation Cancer Research. 76 |
Morra F, Luise C, Visconti R, et al. (2015) New therapeutic perspectives in CCDC6 deficient lung cancer cells. International Journal of Cancer. 136: 2146-57 |
Akerman KJ, Fagenson AM, Cyril V, et al. (2014) Gold(III) macrocycles: nucleotide-specific unconventional catalytic inhibitors of human topoisomerase I. Journal of the American Chemical Society. 136: 5670-82 |
Méndez-Lucio O, Tran J, Medina-Franco JL, et al. (2014) Toward drug repurposing in epigenetics: olsalazine as a hypomethylating compound active in a cellular context. Chemmedchem. 9: 560-5 |
Smith S, Fox J, Mejia M, et al. (2014) Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity. Plos One. 9: e87203 |